News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,656 Results
Type
Article (46227)
Company Profile (333)
Press Release (711077)
Multimedia
Podcasts (120)
Webinars (23)
Section
Business (212749)
Career Advice (2196)
Deals (36566)
Drug Delivery (129)
Drug Development (82881)
Employer Resources (177)
FDA (17061)
Job Trends (15465)
News (358256)
Policy (33768)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2762)
Accelerated approval (42)
Adcomms (27)
Allergies (165)
Alliances (52708)
ALS (196)
Alzheimer's disease (1772)
Antibody-drug conjugate (ADC) (381)
Approvals (17363)
Artificial intelligence (646)
Autoimmune disease (229)
Automation (52)
Bankruptcy (367)
Best Places to Work (11957)
BIOSECURE Act (20)
Biosimilars (204)
Biotechnology (222)
Bladder cancer (180)
Brain cancer (64)
Breast cancer (695)
Cancer (5400)
Cardiovascular disease (452)
Career advice (1863)
Career pathing (41)
CAR-T (312)
CDC (56)
Celiac Disease (2)
Cell therapy (832)
Cervical cancer (42)
Clinical research (71188)
Collaboration (1980)
Company closure (5)
Compensation (1281)
Complete response letters (70)
COVID-19 (2820)
CRISPR (106)
C-suite (1011)
Cystic fibrosis (154)
Data (7122)
Decentralized trials (3)
Denatured (44)
Depression (157)
Dermatology (58)
Diabetes (555)
Diagnostics (7119)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (310)
Drug pricing (197)
Drug shortages (31)
Duchenne muscular dystrophy (273)
Earnings (92818)
Editorial (61)
Employer branding (22)
Employer resources (157)
Events (123486)
Executive appointments (1069)
FDA (20553)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1671)
Gene editing (226)
Generative AI (58)
Gene therapy (688)
GLP-1 (1043)
Government (4819)
Grass and pollen (7)
Guidances (398)
Healthcare (19696)
HIV (77)
Huntington's disease (54)
IgA nephropathy (91)
Immunology and inflammation (277)
Immuno-oncology (82)
Indications (158)
Infectious disease (3141)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (281)
Interviews (351)
IPO (17005)
IRA (51)
Job creations (3843)
Job search strategy (1554)
JPM (62)
Kidney cancer (18)
Labor market (93)
Layoffs (570)
Leadership (38)
Legal (8247)
Liver cancer (100)
Longevity (28)
Lung cancer (721)
Lymphoma (409)
Machine learning (54)
Management (63)
Manufacturing (942)
MASH (177)
Medical device (14618)
Medtech (14699)
Mergers & acquisitions (20732)
Metabolic disorders (1426)
mRNA (195)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (391)
Neuropsychiatric disorders (98)
Neuroscience (3190)
Neurotech (1)
NextGen: Class of 2026 (6888)
Non-profit (4692)
Now hiring (73)
Obesity (670)
Opinion (297)
Ovarian cancer (187)
Pain (231)
Pancreatic cancer (258)
Parkinson's disease (343)
Partnered (34)
Patents (569)
Patient recruitment (603)
Peanut (63)
People (61620)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (22344)
Phase 2 (31312)
Phase 3 (23239)
Pipeline (7195)
Policy (316)
Postmarket research (2593)
Preclinical (9566)
Press Release (71)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (323)
Rare diseases (1010)
Real estate (6298)
Recruiting (70)
Regulatory (25673)
Reports (54)
Research institute (2562)
Resumes & cover letters (369)
Rett syndrome (32)
RNA editing (20)
RSV (87)
Schizophrenia (167)
Series A (281)
Series B (203)
Service/supplier (14)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3900)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (73)
Vaccines (1103)
Venture capital (104)
Weight loss (430)
Women's health (112)
Worklife (19)
Date
Today (121)
Last 7 days (676)
Last 30 days (2798)
Last 365 days (30797)
2026 (8186)
2025 (31008)
2024 (36260)
2023 (41187)
2022 (52437)
2021 (57062)
2020 (55710)
2019 (48558)
2018 (36575)
2017 (33618)
2016 (33226)
2015 (39449)
2014 (33025)
2013 (28097)
2012 (30364)
2011 (30965)
2010 (28912)
Location
Africa (790)
Alabama (93)
Alaska (7)
Arizona (343)
Arkansas (15)
Asia (42304)
Australia (7037)
California (12486)
Canada (3534)
China (1259)
Colorado (533)
Connecticut (536)
Delaware (379)
Europe (93182)
Florida (1861)
Georgia (407)
Hawaii (3)
Idaho (65)
Illinois (988)
India (81)
Indiana (569)
Iowa (23)
Japan (497)
Kansas (133)
Kentucky (47)
Louisiana (40)
Maine (73)
Maryland (1507)
Massachusetts (9028)
Michigan (374)
Minnesota (695)
Mississippi (7)
Missouri (149)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (89)
New Jersey (3329)
New Mexico (30)
New York (3286)
North Carolina (1603)
North Dakota (10)
Northern California (6144)
Ohio (376)
Oklahoma (24)
Oregon (44)
Pennsylvania (2512)
Puerto Rico (27)
Rhode Island (51)
South America (1178)
South Carolina (77)
South Dakota (1)
Southern California (4909)
Tennessee (203)
Texas (1975)
United States (44427)
Utah (376)
Vermont (1)
Virginia (298)
Washington D.C. (82)
Washington State (1009)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
757,656 Results for "interactive motion technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
December 30, 2025
·
9 min read
Press Releases
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness
December 5, 2025
·
4 min read
Press Releases
Nivalon Medical Produces the World’s First Fully Patient-Specific, Motion-Preserving, Metal-Free Spinal Implant Using AI and Advanced Ceramic 3D Printing
January 30, 2026
·
6 min read
Press Releases
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
December 1, 2025
·
4 min read
Approvals
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are dissatisfied with existing treatments.
January 2, 2026
·
3 min read
·
Nick Paul Taylor
Press Releases
Hubly Surgical awarded Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc.
March 3, 2026
·
2 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
March 12, 2026
·
5 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Reports 63% Revenue Growth, Strong Profitability, and Significant Cash Flow Improvement in 2025
March 26, 2026
·
3 min read
1 of 75,766
Next
